Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

AZD-0364 MeSH Supplementary Concept Data 2025


MeSH Supplementary
AZD-0364
Unique ID
C000717867
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C000717867
Entry Term(s)
(6R)-7-(3,4-Difluorobenzyl)-6-(methoxymethyl)-2-(5-methyl-2-((1-methyl-1H-pyrazol-5-yl)amino)-4-pyrimidinyl)-6,7-dihydroimidazo(1,2-a)pyrazin-8(5H)-one
AZD0364
imidazo(1,2-a)pyrazin-8(5H)-one, 7-((3,4-difluorophenyl)methyl)-6,7-dihydro-6-(methoxymethyl)-2-(5-methyl-2-((1-methyl-1H-pyrazol-5-yl)amino)-4-pyrimidinyl)-, (6R)-
Registry Numbers
VO9KX45QIQ
Heading Mapped to
*Imidazoles
*Pyrazines
*Pyrimidines
Frequency
2
Note
oral inhibitor of ERK1 and ERK2
Source
J Med Chem . 2019 Dec 26;62(24):11004-11018.
Date of Entry
2021/06/25
Revision Date
2021/06/25
AZD-0364 Preferred
(6R)-7-(3,4-Difluorobenzyl)-6-(methoxymethyl)-2-(5-methyl-2-((1-methyl-1H-pyrazol-5-yl)amino)-4-pyrimidinyl)-6,7-dihydroimidazo(1,2-a)pyrazin-8(5H)-one Broader
page delivered in 0.005s